A 3-month period of electronic monitoring can provide important information to the healthcare team to assess adherence and improve asthma control

Anja Jochmann; Luca Artusio; Jakob Usemann; Angela Jamalzadeh; Andrew Bush; Urs Frey; Louise J. Fleming

doi:10.1183/23120541.00726-2020

Tables

TABLE 1

Change in asthma control parameters between baseline, follow-up 1 and follow-up 2

	Baseline (n=35)	Follow-up 1 (n=35)	Follow-up 2 (n=35)	*p-value: comparison baseline versus* follow-up 1**	*p-value: comparison follow-up 1 versus* follow-up 2**
FEV₁, % pred	82.2±21.8	92.5±16.1	95.8±16.2	<0.001	0.087
BDR, %	20.3±22.8^#	8.7±10.4^#	7.2±9.3^¶	<0.001	0.445
F_eNO, ppb	55 (26–87)^¶	21 (13–61)^¶	22.5 (11–40)⁺	0.002	0.724
mPAQLQ	3.5 (3–4.7)	5.5 (4.3–6.4)	5.9 (4.3–6.8)^¶	0.001	0.006
Exacerbations, n	2 (0–8)	1 (0–4)^#	0 (0–4)	0.033	0.001
Adherence	Not assessed	78 (54–92)	83 (56–93)		0.302
ACT	12.6±6.1^#	16.2±6.1^#	19.1±5.8^¶	0.001	0.005

Data are presented as mean±sd or median (interquartile range), unless otherwise stated. According to the data distribution, Wilcoxon signed rank or paired t-test were used. FEV₁: forced expiratory volume in 1 s; BDR: bronchodilator reversibility; F_eNO: exhaled nitric oxide fraction; mPAQLQ: median paediatric quality of life questionnaire score; ACT: Asthma Control Test. ^#: missing data for one child; ^¶: missing data for two children; ⁺: missing data for five children.